Research
Charlotte Gastro Research Department
We offer an extensive gastrointestinal research department in Charlotte
Charlotte Gastro is committed to advancing its patients with every resource available, including research studies, for the treatment of gastrointestinal and liver disease. For over two decades, we have participated in numerous national research studies, including Phase II, III, and IV trials.
Clinical Trials
Current Research & Clinical Trials
We are currently enrolling patients in Phase lll and IV trials in the following therapeutic areas:
Successful Clinical Trials
Years of Excellence
Customer Satisfaction Rating
Ulcerative Colitis
We are enrolling patients with moderately to severely active Ulcerative Colitis in trials evaluating new therapeutic options.
Now Enrolling
Crohn’s Disease
We are enrolling patients with active Crohn's Disease in trials studying emerging therapies for sustained remission.
Now Enrolling
Fatty Liver Disease
We are enrolling patients with Fatty Liver Disease (MAFLD/NASH) in trials targeting liver fibrosis and compensated cirrhosis.
Now Enrolling
CLINICAL RESEARCHERS
Investigator Experience & Staff Expertise
Charlotte Gastroenterology & Hepatology consists of 23 physicians who are all board certified in gastroenterology. While Dr. Gardiner Roddey and Dr. Jason Wilson are the directors of clinical research at the CGH Research Division, nearly all of our physicians participate as sub-investigators.
Gardiner Roddey, MD
LEARN MORE
Jason A. Wilson, MD, AGAF, FACG
LEARN MORE
Kate Baade, RN, BSN
LEARN MORE
Macie Wilson Johnson, MS
LEARN MORE
THERAPEUTIC SPECIALTIES
Conditions We Study
We have conducted and are currently conducting studies for these conditions:
Cirrhosis
Severe scarring of the liver, a late stage of chronic liver disease caused by many forms of liver conditions and diseases, preventing proper function.
Crohn’s Disease
A chronic inflammatory bowel disease causing inflammation anywhere along the digestive tract, leading to abdominal pain, severe diarrhea, fatigue, and malnutrition.
GERD & Dyspepsia
Chronic digestive conditions in which stomach acid flows back into the esophagus or causes persistent upper abdominal discomfort, bloating, and indigestion.
Ulcerative Colitis
A chronic inflammatory bowel disease causing long-lasting inflammation and ulcers in the innermost lining of the large intestine and rectum.
PARTNERSHIPS
Academic Institutions
Our active research program keeps us at the forefront of gastroenterology, giving our patients access to cutting-edge therapies and clinical trials.
Cedars Sinai Medical Center
Duke University Medical Center
Massachusetts General Hospital
UNC School of Medicine
Sponsors & CRO's
Companies that help CGH run clinical trials and development, handling tasks like patient recruitment, data management, and regulatory compliance.
- Abbott Laboratories
- Abbvie
- Amgen
- Astra Zeneca
- Berlex Laboratories
- Bristol Myers Squibb
- Pharmaceuticals
- Cato Research
- Celgene
- Celltech Pharmaceuticals
- Centocor
- Cytokine PharmaSciences
Dr. Falk-Pharma
Elan
Forest Laboratories
Glaxo / Smith / Kline
ICON
INC Research
Incara Pharmaceuticals
Inflabloc
InKine Pharmaceutical
Isis Pharmaceuticals
Janssen Pharmaceuticals
- Kendle
- Kentucky Clinical
- Research
- Millennium
- Pharmaceuticals
- Osiris Therapeutics
- Otsuka Pharmaceuticals
- PPD Development
- PRA
- Paragon Biomedical, Inc.
- Pfizer
- Pharmalink FHI
- Pharmanet
Prometheus Therapeutics & Diagnostics
Quintiles
Salix
Schering-Plough
Serono Laboratories
Solvay Pharmaceuticals
Sucampo Pharmaceuticals
Target Health
Trio Clinical Research
UCB
FACULTY
Research Office
Our research office and staff are located in our Randolph Road location. Facilities Include:
- Endoscopy Suites
- EKG
- On site drug infusion room
- Dedicated infusion RN
- H-Pylori breath testing
- Local and central IRB capabilities